same excipients except no hypromellose, PREDNISONE , SAR445761 - belumosudil, PREDNISOLONE
EFC17757
Phase 3 small_molecule active
Quick answer
same excipients except no hypromellose, PREDNISONE , SAR445761 - belumosudil, PREDNISOLONE for chronic graft versus host disease is a Phase 3 program (small_molecule) at Sanofi Pharma Bristol-Myers Squibb with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Sanofi Pharma Bristol-Myers Squibb
- Indication
- chronic graft versus host disease
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active